Global Meningococcal Vaccines Market to Exceed a Value of USD 4.450.4 Million by 2022
Between 2014 and 2022, the global meningococcal vaccines market is estimated to progress at a CAGR of 12.40% to reach a value of USD 4.450.4 million by 2022. Asia-Pacific is expected to grow at a good pace in coming times. The significant improvement in the regional market is will be supported by the governments with awareness programs and immunization campaigns.
View full press release